auto_awesome_motion View all 1 versions
organization

TPIZ

TAKEDA PHARMACEUTICALS INTERNATIONAL AG
Country: Switzerland
24 Projects, page 1 of 5
  • Open Access mandate for Publications
    Funder: EC Project Code: 101005177
    Overall Budget: 10,329,300 EURFunder Contribution: 9,592,030 EUR
    Partners: UCL, Labormedizinische Zentrum Dr Risch (Switzerland), UMC, ROCHE DIAGNOSTICS NEDERLAND BV, Julius Clinical, VIVE - Det Nationale Forsknings- og Analysecenter For Velfærd, TPIZ, AVA AG, Stichting Sanquin Bloedvoorziening

    In this project, we will evaluate the use and performance of a CE-marked device (wearable), which uses sensors to measure breathing rate, pulse rate, skin temperature, and heart rate variability for the purpose of early detection and monitoring of COVID-19 in general an...

  • Open Access mandate for Publications and Research data
    Funder: EC Project Code: 821513
    Overall Budget: 2,353,120 EURFunder Contribution: 1,199,120 EUR
    Partners: Janssen (Belgium), PARKINSON'S UK, Roche (Switzerland), AE, NICE, SYNAPSE RESEARCH MANAGEMENT PARTNERS SL, SARD, Eli Lilly and Company Limited, TAKEDA, TPIZ

    The main aim of NEURONET is to set up an efficient platform to boost synergy and collaboration across the IMI projects of the Neurodegenerative Disorders (ND) portfolio, assisting in identifying gaps, multiplying its impact, enhancing its visibility and facilitating dov...

  • Open Access mandate for Publications and Research data
    Funder: EC Project Code: 807012
    Overall Budget: 3,100,690 EURFunder Contribution: 1,750,000 EUR
    Partners: YAMANOUCHI EUROPE BROCADES PHARMA, LASER, Zorginstituut Nederland, Bayer AG, GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD., AstraZeneca (Sweden), VT, UMCG, IAPO, TAKEDA...

    The GetReal Initiative brings together partners from the IMI GetReal project to drive the adoption of tools, methodologies and best practices from IMI GetReal and increase the quality of real-world evidence (RWE) generation in medicines development and regulatory/HTA pr...

  • Open Access mandate for Publications
    Funder: EC Project Code: 806999
    Overall Budget: 7,659,120 EURFunder Contribution: 4,999,760 EUR
    Partners: ALTOIDA SA ALTOIDA LTD, FHG, KI, AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN, KCL, UOXF, TAKEDA, AE, Software (Germany), STICHTING VUMC...

    There is an urgent need for novel approaches assessing functional decline in early AD. The main goal of the RADAR-AD project is to develop a digital platform to detect subtle functional deficits in early Alzheimer’s disease (AD) individuals by integrating a meaningful c...

  • Open Access mandate for Publications
    Funder: EC Project Code: 821362
    Overall Budget: 8,872,610 EURFunder Contribution: 4,599,650 EUR
    Partners: Eli Lilly and Company Limited, DH, FHG, FCDI, TAKEDA, KUL, Bayer AG, Charité - University Medicine Berlin, Janssen (Belgium), UCB Pharma (Belgium)...

    EBiSC2 builds on the achievements of the European Bank for iPSCs (EBiSC1) in centralising existing capacities across Europe in a unique banking and distribution infrastructure for research use in response to the increasing demand for human induced pluripotent stem cells...